Charles River Laboratories (CRL) Stock Forecast & Price Target

CRL price $376.88 +2.90 +0.78%

Ticker
CRL
Price
$376.88
Change
+2.90 +0.78%
Market cap ?
$18.15B
P/E ?
-77.27
Forward P/E ?
33.12
Dividend yield ?
0.00%
Beta ?
1.40
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
26
Value
20
Quality
48
Growth
10

Stocklytics score rationale: value 20, quality 48, growth 10.

Financials

2016201720182019202020212022202320242025
1681432000185760100022660960002621226000292393300035401600003976060000412940900040499890004015382000

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific…

Fair value

CRL fair value $253.97. Price $376.88. Price is 48% above fair value.

Above fair value, and more expensive than usual. A larger premium than on 91% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 370.61M. Growth 12.50%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.4). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 48.17M. Net debt 2.85B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CRL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—2.97—960.36M
2026-08-053.022.741.00B977.20M
2026-05-072.061.96995.83M977.46M
2026-02-182.392.33994.23M987.02M
2025-11-052.432.321.00B987.20M
2025-08-063.122.501.03B968.92M
2025-05-072.342.06984.17M958.79M
2025-02-192.662.501.00B948.22M
2024-11-062.592.421.01B975.99M
2024-08-072.802.391.03B1.02B
2024-05-092.272.061.01B992.31M
2024-02-142.462.391.01B991.25M
2023-11-082.722.351.03B1.00B
2023-08-092.692.631.06B1.05B
2023-05-112.782.591.03B986.35M
2023-02-222.982.751.10B1.04B
2022-11-022.632.51989.16M970.43M
2022-08-032.772.73973.13M995.18M
2022-05-042.752.71913.93M910.10M
2022-02-162.492.43905.05M888.27M
2021-11-032.702.57895.94M850.62M
2021-08-042.612.39914.61M880.44M
2021-05-042.532.19824.57M798.53M
2021-02-172.392.11790.99M756.60M
2020-10-292.331.80743.30M574.22M
2020-08-051.581.26682.58M544.34M
2020-05-071.841.48707.06M568.72M
2020-02-112.011.83691.14M632.68M
2019-11-061.691.63667.95M644.24M
2019-07-311.631.55657.57M625.29M
2019-05-071.401.38604.57M595.93M
2019-02-131.491.40601.53M565.20M
2018-11-071.531.38585.29M527.92M
2018-08-081.621.46585.30M527.49M
2018-05-101.381.26493.97M451.04M
2018-02-131.401.26478.48M427.23M
2017-11-091.301.22464.23M435.63M
2017-08-091.291.22469.13M443.64M
2017-05-101.291.14445.76M393.96M
2017-02-141.211.11466.79M428.22M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-22FOSTER JAMES CBuy24.04K$244.415.88M
2026-10-22FOSTER JAMES CSell24.04K$350.008.41M
2026-10-22FOSTER JAMES CSell24.04K$244.415.88M
2026-10-21Parisotto Shannon MBuy2.16K$244.41526.95K
2026-10-21Parisotto Shannon MSell2.16K$344.41742.55K
2026-10-21Parisotto Shannon MSell2.16K$244.41526.95K
2026-10-05Parisotto Shannon MBuy981$208.44204.48K
2026-10-05Parisotto Shannon MSell981$308.44302.58K
2026-10-05Parisotto Shannon MSell981$208.44204.48K
2026-09-30Coleman GlennBuy10$297.432.97K
2026-08-25FOSTER JAMES CBuy12.43K$208.442.59M
2026-08-25FOSTER JAMES CBuy21.13K$194.124.10M
2026-08-25FOSTER JAMES CSell33.56K$300.0010.07M
2026-08-25FOSTER JAMES CSell12.43K$208.442.59M
2026-08-25FOSTER JAMES CSell21.13K$194.124.10M
2026-08-19Girshick BirgitSell528——
2026-08-19Parisotto Shannon MBuy2.04K$194.12395.81K
2026-08-19Parisotto Shannon MSell2.04K$294.12599.71K
2026-08-19Parisotto Shannon MSell2.04K$194.12395.81K
2026-08-18Andrews Nancy CBuy573$164.3094.14K
2026-08-18Andrews Nancy CSell573$285.24163.44K
2026-08-18Andrews Nancy CSell573$164.3094.14K
2026-08-11Girshick BirgitBuy6.50K$179.661.17M
2026-08-11Girshick BirgitSell6.50K$279.901.82M
2026-08-11Girshick BirgitSell6.50K$179.661.17M
2026-08-11Parisotto Shannon MBuy3.71K$179.66667.26K
2026-08-11Parisotto Shannon MSell3.71K$279.661.04M
2026-08-11Parisotto Shannon MSell3.71K$179.66667.26K
2026-08-10LaPlume Joseph WSell257——
2026-08-10FOSTER JAMES CBuy28.73K$179.665.16M
2026-08-10FOSTER JAMES CSell28.73K$275.007.90M
2026-08-10FOSTER JAMES CSell28.73K$179.665.16M
2026-08-06Knell Michael GunnarSell1.27K$259.07330.06K
2026-08-06Knell Michael GunnarBuy736$208.44153.41K
2026-08-06Knell Michael GunnarSell901$260.63234.83K
2026-08-06Knell Michael GunnarSell404$258.53104.45K
2026-08-06Knell Michael GunnarBuy1.21K$194.12233.91K
2026-08-06Knell Michael GunnarSell810$261.45211.77K
2026-08-06Knell Michael GunnarSell213$262.3755.88K
2026-08-06Knell Michael GunnarSell1.21K$258.53311.53K
2026-08-06Knell Michael GunnarSell620$263.94163.64K
2026-08-06Knell Michael GunnarBuy404$179.6672.58K
2026-08-06Knell Michael GunnarSell736$258.53190.28K
2026-08-06Knell Michael GunnarSell482$265.17127.81K
2026-08-06Knell Michael GunnarSell736$208.44153.41K
2026-08-06Knell Michael GunnarSell1.21K$194.12233.91K
2026-08-06Knell Michael GunnarSell404$179.6672.58K
2026-08-06Creamer Victoria LBuy4.18K$179.66750.80K
2026-08-06Creamer Victoria LSell4.18K$259.161.08M
2026-08-06Creamer Victoria LSell4.18K$179.66750.80K
2026-08-05Parisotto Shannon MSell5.05K$263.001.33M
2026-06-29FOSTER JAMES CSell75.00K$225.0016.88M
2026-06-05FOSTER JAMES CBuy153.36K——
2026-06-05FOSTER JAMES CSell153.36K——
2026-06-05FOSTER JAMES CSell20.00K——
2026-06-05FOSTER JAMES CBuy20.00K——
2026-06-05FOSTER JAMES CBuy10.00K——
2026-06-05FOSTER JAMES CSell10.00K——
2026-06-05Girshick BirgitBuy3.39K——
2026-06-05Girshick BirgitSell3.39K——
2026-06-05Parisotto Shannon MSell1.53K——
2026-06-05Parisotto Shannon MBuy1.53K——
2026-06-02Barg StevenBuy422$174.7973.76K
2026-05-31Mintz MarkSell64$180.7111.57K
2026-05-31LaPlume Joseph WSell235$180.7142.47K
2026-05-31Knell Michael GunnarSell48$180.718.67K
2026-05-31Girshick BirgitSell378$180.7168.31K
2026-05-31Creamer Victoria LSell194$180.7135.06K
2026-05-31Parisotto Shannon MSell170$180.7130.72K
2026-05-30Mintz MarkSell305$180.7155.12K
2026-05-30LaPlume Joseph WSell744$180.71134.45K
2026-05-30Knell Michael GunnarSell152$180.7127.47K
2026-05-30Girshick BirgitSell1.20K$180.71217.57K
2026-05-30FOSTER JAMES CSell1.60K$180.71288.41K
2026-05-30Creamer Victoria LSell616$180.71111.32K
2026-05-30Parisotto Shannon MSell551$180.7199.57K
2026-05-29Coleman GlennBuy6.64K$180.711.20M
2026-05-29Mintz MarkBuy2.53K$180.71457.92K
2026-05-29LaPlume Joseph WBuy5.26K$180.71949.99K
2026-05-29Knell Michael GunnarBuy1.84K$180.71331.96K
2026-05-29Girshick BirgitBuy9.96K$180.711.80M
2026-05-29Creamer Victoria LBuy5.13K$180.71927.95K
2026-05-29Parisotto Shannon MBuy4.36K$180.71788.08K
2026-05-27Creamer Victoria LSell148$156.7323.20K
2026-05-27Parisotto Shannon MSell105$156.7316.46K
2026-05-27Mintz MarkSell47$156.737.37K
2026-05-27Girshick BirgitSell242$156.7337.93K
2026-05-27Knell Michael GunnarSell37$156.735.80K
2026-05-27LaPlume Joseph WSell185$156.7329.00K
2026-05-26Creamer Victoria LSell198$160.3031.74K
2026-05-26Parisotto Shannon MSell168$160.3026.93K
2026-05-26Mintz MarkSell64$160.3010.26K
2026-05-26Girshick BirgitSell376$160.3060.27K
2026-05-26Knell Michael GunnarSell50$160.308.02K
2026-05-26LaPlume Joseph WSell243$160.3038.95K
2026-05-12Andrews Nancy CBuy3.96K——
2026-05-12Andrews Nancy CSell3.96K——
2026-05-08Barg StevenBuy1.44K$177.62255.42K
2026-05-08Thompson Craig B.Buy1.44K$177.62255.42K
2026-05-08Graves Paul WBuy1.44K$177.62255.42K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 585, holders +10 vs prior quarter. Ownership 118.20%.

HolderSharesChangeChange %Value
FMR LLC4.24M783.51K+22.67%961.53M
BLACKROCK, INC.3.80M-60.54K-1.57%861.48M
VANGUARD CAPITAL MANAGEMENT LLC3.15M-52.92K-1.65%714.23M
INVESCO LTD.2.98M587.53K+24.51%676.92M
HARRIS ASSOCIATES L P2.24M87.85K+4.08%508.27M
VANGUARD PORTFOLIO MANAGEMENT LLC2.21M-83.69K-3.65%501.43M
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC1.91M-88.07K-4.42%436.47M
STATE STREET CORP1.86M-9.33K-0.50%422.80M
DIMENSIONAL FUND ADVISORS LP1.65M-4.03K-0.24%373.85M
ARIEL INVESTMENTS, LLC1.51M62.00K+4.29%341.59M
PRICE T ROWE ASSOCIATES INC /MD/1.51M380.23K+33.79%341.40M
GEODE CAPITAL MANAGEMENT, LLC1.31M44+0.00%295.60M
WELLINGTON MANAGEMENT GROUP LLP1.29M-340.94K-20.92%292.21M
CITADEL ADVISORS LLC1.19M-18.55K-1.53%270.70M
BANK OF AMERICA CORP /DE/1.17M37.56K+3.31%265.93M
EARNEST PARTNERS LLC1.12M148.65K+15.30%254.01M
AMERIPRISE FINANCIAL INC881.19K-228.20K-20.57%199.83M
NEUBERGER BERMAN GROUP LLC862.70K-11.67K-1.34%195.63M
SEI INVESTMENTS CO813.53K56.40K+7.45%184.50M
MORGAN STANLEY800.49K-25.18K-3.05%181.54M
CLEARBRIDGE INVESTMENTS, LLC781.28K148.65K+23.50%177.19M
COOKE & BIELER LP755.63K-112.29K-12.94%171.37M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/682.17K-226.68K-24.94%157.64M
VICTORY CAPITAL MANAGEMENT INC664.77K-78.58K-10.57%150.76M
UBS GROUP AG646.75K-84.72K-11.58%146.68M

Forecast

Consensus Buy from 18 analysts. Average price target $308.36, -18.2% versus the current price. Low $219.00. High $357.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $308.36 for Charles River Laboratories International (CRL), 18.4% below the current price of $377.77. Of 18 analysts covering the stock, 15 rate it Buy or Strong Buy, 2 Hold, and 1 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

CRL price target

12-month price target
Low$219.00
Average$308.36
High$357.00

The average is 18.4% below the current price of $377.77.

Is Charles River Laboratories International a buy or sell?

Of 18 analysts, 15 rate Charles River Laboratories International Buy or Strong Buy, 2 Hold, and 1 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Charles River Laboratories International earnings and revenue forecast

Analyst averages on file: 2026, EPS $11.38, revenue $3.92 billion. 2027, EPS $12.80, revenue $4.01 billion.

CRL score and fair value

The Stocklytics Score for CRL is 26 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

CRL forecast FAQs

What is the CRL price target?

$308.36 average, with a published range of $219.00 to $357.00.

Is Charles River Laboratories International a buy or sell?

The consensus is Buy from 18 analysts. This is not a recommendation.

What is the Charles River Laboratories International stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is $11.38. The average revenue estimate is $3.92 billion.

What will CRL be worth in 2030?

No reliable forecast exists that far out.

When is Charles River Laboratories International's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Charles River Laboratories International · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Charles River Laboratories (CRL) Stock Forecast & Price Target

CRL$376.88+2.90 +0.78%

$18.15B

Market Cap

-77.27

P/E

33.12

Forward P/E

26

Score

Price History